The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Mcfarlane Neil F. since 2017.
This trader's CIK number is 1681098.
At the time of last reporting, Mcfarlane Neil F. was the President and CEO of Zevra Therapeutics, Inc.. (stock ticker symbol ZVRA).
Also see all insider trading activities at Zevra Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | ZVRA | 0 | $0 | 91,817 | $727,391 | 233,333 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | RTRX | 0 | $0 | 1,968 | $35,905 | 0 | $0 |
| 2018 | RTRX | 0 | $0 | 21,125 | $489,235 | 0 | $0 |
| 2017 | RTRX | 0 | $0 | 1,378 | $31,005 | 0 | $0 |
1. Zevra Therapeutics, Inc. (ZVRA)
2. Travere Therapeutics, Inc. (RTRX)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-02-13 | ZVRA | Sale | 61,273 | 7.86 | 481,421 |
| 2025-02-14 | ZVRA | Sale | 30,544 | 8.05 | 245,970 |
| 2025-01-31 | ZVRA | Option Ex | 233,333 | .00 | 0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-05-16 | RTRX | Sale | 984 | 18.71 | 18,410 |
| 2019-05-15 | RTRX | Sale | 984 | 17.78 | 17,495 |
| 2018-12-20 | RTRX | Sale | 11,125 | 22.28 | 247,865 |
| 2018-11-14 | RTRX | Sale | 10,000 | 24.14 | 241,370 |
| 2017-08-16 | RTRX | Sale | 1,378 | 22.50 | 31,005 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mcfarlane Neil F. (President and CEO of Zevra Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.